Position in TYRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,903,655
-$1,051,916 QoQ
Shares Held
59,601
-22.8% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 169 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 0%
Shared 70%
None 30%
Common Shares in TYRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. TYRA ranks #126 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in TYRA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,903,655 | 59,601 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,955,571 | 77,169 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,742,177 | 104,305 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,159,364 | 82,871 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $986,455 | 103,078 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $968,008 | 104,087 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,318,539 | 94,859 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,135,295 | 90,825 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,871,339 | 117,032 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,669,322 | 101,788 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,418,738 | 102,436 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $1,295,921 | 94,112 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,352,794 | 79,436 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,354,057 | 84,260 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $593,977 | 78,155 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $748,749 | 85,182 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $392,276 | 54,864 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,688,074 | 251,222 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,298,273 | 589,785 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $12,231,573 | 695,371 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||